CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

G6PD deficiency — rasburicase contraindicated

Gene: G6PD · Type: variant

Indications: Hematologic malignancy

SensitivityResistanceCIViC Context

FDA Resistance Assertions

DrugIndicationRecommendationFDA SourceLink
RasburicaseHematologic malignancyCONTRAINDICATED
FDA Label
Label